OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.57 | Prev. Close $0.60 | Circuit Range N/A |
Day Range $0.57 - $0.60 | Year Range $0.52 - $13.40 | Volume 5,863 |
Average Traded $0.60 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $0.57 | $0.61 | +0.00% |
12-Nov-25 | $0.57 | $0.61 | +9.09% |
11-Nov-25 | $0.55 | $0.56 | -2.94% |
10-Nov-25 | $0.61 | $0.58 | -3.67% |
07-Nov-25 | $0.60 | $0.60 | -10.18% |
06-Nov-25 | $0.62 | $0.67 | +12.65% |
05-Nov-25 | $0.61 | $0.59 | -5.72% |